CXCR2 and neoplasm: In the spontaneous KPC mouse model of pre-invasive pancreatic cancer, there were no differences in overall or tumor-free survival between wild-type and CXCR2−/− mice; however, genetic deletion of CXCR2 significantly reduced metastasis in mice greater than 10 weeks old [42].